Your browser doesn't support javascript.
loading
Potential therapeutic target secretogranin II might cooperate with hypoxia-inducible factor 1α in sunitinib-resistant renal cell carcinoma.
Fukumoto, Wataru; Yoshino, Hirofumi; Horike, Shin-Ichi; Kawakami, Issei; Tamai, Motoki; Arima, Junya; Kawahara, Ichiro; Mitsuke, Akihiko; Sakaguchi, Takashi; Inoguchi, Satoru; Meguro-Horike, Makiko; Tatarano, Shuichi; Enokida, Hideki.
Afiliação
  • Fukumoto W; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
  • Yoshino H; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
  • Horike SI; Division of Functional Genomics, Advanced Science Research Center, Kanazawa University, Kanazawa, Japan.
  • Kawakami I; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
  • Tamai M; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
  • Arima J; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
  • Kawahara I; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
  • Mitsuke A; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
  • Sakaguchi T; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
  • Inoguchi S; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
  • Meguro-Horike M; Division of Functional Genomics, Advanced Science Research Center, Kanazawa University, Kanazawa, Japan.
  • Tatarano S; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
  • Enokida H; Department of Urology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
Cancer Sci ; 114(10): 3946-3956, 2023 Oct.
Article em En | MEDLINE | ID: mdl-37545017

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Cancer Sci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Cancer Sci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão